ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Vafseo 300 mg, Filmtabletten - 28
68862003 Salmon Pharma GmbH
Vafseo 300 mg, Filmtabletten19.06.2023
  19.06.2023
Vadadustat (B03XA08) 
WHO-DDD18.06.2028
28
06.07.30. 
A  
No 
IP 
PR  
k.A.PR
  
7680688620030Synthetika
  
Composition
vadadustatum 300 mg, cellulosum microcristallinum, carboxymethylamylum natricum A, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), pro compresso obducto corresp. natrium 0.77 - 1.15 mg.
Packungsbestandteile
Coated tablets
 
Active AgentDose
Vadadustatum300 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
Carboxymethylamylum Natricum A  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Hypromellosum  
Macrogol3350  
Magnesii Stearas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home